Sonal Bhatia from Pfizer: Consistency in Data For The Last 5 Years
Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC).
Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC). Bhatia further discussed the ACROPOLIS program, a global study comparing apixaban and other anti-coagulants including warfarin, which had shown significant reduction in bleeding. Accoring to Bhatia, having the global purview is critical allowing methods to compare trends for targeted research.
